Rockefeller Capital Management L.P. Meira G Tx Holdings PLC Transaction History

Rockefeller Capital Management L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$5.19 - $8.07 $3,025 - $4,704	-583 Reduced 3.31%	17,040 $114,000
Q1 2023 May 17, 2023	BUY	$5.04 - $8.6 $58,277 - $99,441	11,563 Added 190.81%	17,623 $91,000
Q4 2022 Mar 06, 2023	BUY	$5.8 - $8.98 $4,553 - $7,049	785 Added 14.88%	6,060 $39,000
Q3 2022 Nov 02, 2022	SELL	$7.55 - $11.25 $22,650 - $33,750	-3,000 Reduced 36.25%	5,275 $44,000
Q2 2022 Aug 12, 2022	BUY	$6.8 - $14.23 $20,400 - $42,690	3,000 Added 56.87%	8,275 $62,000
Q1 2022 May 13, 2022	BUY	$13.42 - $23.38 $9,058 - $15,781	675 Added 14.67%	5,275 $73,000
Q4 2021 Feb 14, 2022	BUY	$12.78 - $23.74 $19,170 - $35,610	1,500 Added 48.39%	4,600 $109,000
Q3 2021 Nov 12, 2021	BUY	$11.73 - $16.08 $35,190 - $48,239	3,000 Added 3000.0%	3,100 $40,000
Q2 2021 Aug 10, 2021	BUY	$12.85 - $16.2 $1,285 - $1,620	100 New	100 $1,000
Q1 2020 May 12, 2020	SELL	$9.31 - $21.24 $2,327 - $5,310	-250 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$9.2 - $21.21 $2,300 - $5,302	250 New	250 $4,000

100

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $288M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.